Literature DB >> 28149251

A major burn injury in a liver transplant patient.

I Delikonstantinou1, B Philp1, D Kamel2, D Barnes1, P Dziewulski1.   

Abstract

Immunosuppressive therapy may aggravate the clinical course of a burned patient, primarily affecting wound healing and thus complicating permanent wound coverage. We hereby present the successful management of a 48-year-old female liver transplant recipient with a major burn injury, aiming to elucidate the effects of the patient's immunosuppression on surgical treatment. After admission to the Burns ITU, the patient underwent serial debridement of the burn and coverage with cryopreserved allografts. Despite immunosuppression, no prolonged survival of the allo-epidermis was documented. Nevertheless, a variable degree of vascularized allo-dermis was clinically identified. She subsequently underwent skin autografting and was discharged home with most of the wounds healed. Although there are isolated reports of survival of skin allografts in immunocompromised patients, in our case the allografted skin did not provide permanent wound coverage. However, it permitted a staged surgical management, allowing the immunosuppressive regime to change, the skin donor sites to heal and it also provided a dermal scaffold for successful skin autografting.

Entities:  

Keywords:  allografts; burn injury; immunosuppressive therapy; liver transplant

Year:  2016        PMID: 28149251      PMCID: PMC5266239     

Source DB:  PubMed          Journal:  Ann Burns Fire Disasters        ISSN: 1592-9558


  12 in total

Review 1.  Effects of immunosuppressive therapy on wound healing.

Authors:  Roshan Bootun
Journal:  Int Wound J       Date:  2012-02-24       Impact factor: 3.315

2.  The skin allograft revisited: a potentially permanent wound coverage option in the critically ill patient.

Authors:  Bohdan Pomahac; Jesus A Garcia; Alexander J Lazar; Nicholas Tilney; Dennis P Orgill
Journal:  Plast Reconstr Surg       Date:  2009-06       Impact factor: 4.730

3.  Successful surgical treatment of severe burn in an immunocompromised patient under long-term treatment for frequently relapsing nephrotic syndrome.

Authors:  Hajime Matsumine; Kousuke Morioka; Hiroshi Kawate; Kazunobu Sueyoshi; Sumika Matsukita; Kazutaka Soejima; Hiroyuki Sakurai
Journal:  J Burn Care Res       Date:  2011 May-Jun       Impact factor: 1.845

4.  How long can cryopreserved skin be stored to maintain adequate graft performance?

Authors:  H Ben-Bassat; M Chaouat; N Segal; E Zumai; M R Wexler; A Eldad
Journal:  Burns       Date:  2001-08       Impact factor: 2.744

5.  Effect of storage and preservation methods on viability in transplantable human skin allografts.

Authors:  D Bravo; T H Rigley; N Gibran; D M Strong; H Newman-Gage
Journal:  Burns       Date:  2000-06       Impact factor: 2.744

6.  Management of side effects of sirolimus therapy.

Authors:  Giovanni Stallone; Barbara Infante; Giuseppe Grandaliano; Loreto Gesualdo
Journal:  Transplantation       Date:  2009-04-27       Impact factor: 4.939

7.  Incidence of abdominal wall numbness post-liver transplantation and its complications.

Authors:  Ashokkumar Jain; Pauline Nemitz; Rajeev Sharma; Baber Sheikh; Saman Safadjou; Marry Vetter; Leah Brayan; Pam Batzold; Randeep Kashyap; Mark Orloff
Journal:  Liver Transpl       Date:  2009-11       Impact factor: 5.799

8.  Cyclosporin A treatment failed to extend skin allograft survival in two burn patients.

Authors:  A Eldad; P Benmeir; A Weinberg; A Neuman; M Chaouat; H Ben-Bassat; M R Wexler
Journal:  Burns       Date:  1994-06       Impact factor: 2.744

9.  Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.

Authors:  Patrick G Dean; William J Lund; Timothy S Larson; Mikel Prieto; Scott L Nyberg; Michael B Ishitani; Walter K Kremers; Mark D Stegall
Journal:  Transplantation       Date:  2004-05-27       Impact factor: 4.939

10.  Long-term survival of human skin allografts in patients with immunosuppression.

Authors:  James Robert Wendt; Tom Ulich; P Nagesh Rao
Journal:  Plast Reconstr Surg       Date:  2004-04-15       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.